UBS Group Forecasts Strong Price Appreciation for Procter & Gamble (NYSE:PG) Stock

Procter & Gamble (NYSE:PG) had its price target upped by analysts at UBS Group from $172.00 to $190.00 in a report released on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. UBS Group‘s price target suggests a potential upside of 17.86% from the stock’s previous close.

Other research analysts have also recently issued reports about the company. Sanford C. Bernstein reissued a “market perform” rating and set a $149.00 price target on shares of Procter & Gamble in a research report on Monday, August 24th. Citigroup boosted their price target on Procter & Gamble from $180.00 to $187.00 and gave the stock a “buy” rating in a research report on Friday. Morgan Stanley upped their price objective on Procter & Gamble from $166.00 to $185.00 and gave the stock an “overweight” rating in a research note on Friday. Wells Fargo & Company increased their price objective on Procter & Gamble from $164.00 to $180.00 and gave the company an “overweight” rating in a report on Friday. Finally, TD Cowen raised their target price on shares of Procter & Gamble from $150.00 to $166.00 and gave the company a “hold” rating in a research note on Friday. Fourteen equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $168.55.

Procter & Gamble Stock Down 2.6%

Shares of NYSE PG traded down $4.38 during mid-day trading on Friday, hitting $161.21. The company had a trading volume of 9,769,731 shares, compared to its average volume of 9,752,110. The company has a market capitalization of $374.43 billion, a PE ratio of 24.35, a price-to-earnings-growth ratio of 3.90 and a beta of 0.39. The firm has a 50-day simple moving average of $148.08 and a two-hundred day simple moving average of $146.99. The company has a current ratio of 0.68, a quick ratio of 0.47 and a debt-to-equity ratio of 0.43. Procter & Gamble has a one year low of $137.62 and a one year high of $167.25.

Procter & Gamble (NYSE:PG) last released its earnings results on Thursday, October 22nd. The company reported $2.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.89 by $0.11. Procter & Gamble had a return on equity of 31.36% and a net margin of 18.44%. The business had revenue of $23.28 billion for the quarter, compared to the consensus estimate of $22.80 billion. During the same quarter in the previous year, the business earned $1.99 earnings per share. Procter & Gamble’s quarterly revenue was up 4.0% on a year-over-year basis. On average, equities analysts expect that Procter & Gamble will post 6.98 EPS for the current year.

Insider Buying and Selling at Procter & Gamble

In other news, CFO Andre Schulten sold 3,914 shares of the firm’s stock in a transaction that occurred on Monday, October 5th. The stock was sold at an average price of $145.34, for a total value of $568,860.76. Following the completion of the sale, the chief financial officer directly owned 65,618 shares of the company’s stock, valued at $9,536,920.12. This trade represents a 5.63% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Marc S. Pritchard sold 4,030 shares of Procter & Gamble stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $143.79, for a total value of $579,473.70. Following the transaction, the insider owned 187,001 shares of the company’s stock, valued at $26,888,873.79. This represents a 2.11% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 15,135 shares of company stock valued at $2,189,970 in the last three months. Corporate insiders own 0.23% of the company’s stock.

Hedge Funds Weigh In On Procter & Gamble

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in PG. Mowery & Schoenfeld Wealth Management LLC acquired a new stake in shares of Procter & Gamble during the 2nd quarter worth about $26,000. Montgomery Financial Services LLC bought a new stake in shares of Procter & Gamble during the 2nd quarter worth about $28,000. Paladin Partners LLC acquired a new position in Procter & Gamble in the 2nd quarter valued at about $29,000. Evergreen Advisors LLC bought a new position in Procter & Gamble in the 1st quarter valued at about $37,000. Finally, Toews Corp ADV bought a new position in Procter & Gamble during the 2nd quarter worth $37,000. 65.77% of the stock is owned by institutional investors.

Key Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Better-than-expected fiscal Q1 results: P&G reported adjusted EPS of $2.00 versus the $1.89 consensus, while revenue rose 4% year over year to $23.28 billion, exceeding estimates of about $22.8 billion. Organic sales also increased 4%, supported by 2.4 percentage points of volume growth, favorable product mix and productivity savings. Procter & Gamble earnings beat as sales rise 4%
• Positive Sentiment: Analysts raised targets: Citigroup lifted its target to $187 and assigned a Buy rating, BNP Paribas Exane raised its target to $189 with an Outperform rating, and JPMorgan increased its target to $180 with an Overweight rating. TD Cowen also raised its target to $166, although it maintained a Hold rating. Analyst targets and turnaround outlook
• Positive Sentiment: Defensive and income appeal: P&G’s scale, diversified household-products portfolio and 70-year record of consecutive dividend increases continue to support demand from defensive and income-oriented investors. P&G’s 70-year dividend record
• Neutral Sentiment: Guidance was mixed: P&G forecasts fiscal 2027 EPS of $6.89–$7.11, broadly consistent with the $6.98 consensus. Its $86.0–$87.7 billion revenue outlook was raised partly because of the Thorne acquisition but remains below analysts’ $88.8 billion expectation.
• Negative Sentiment: Commodity inflation threatens margins: Higher oil, raw-material, energy and transportation costs are expected to create a larger annual profit headwind. Analysts caution that pricing and productivity improvements may not fully offset the pressure, leaving the durability of the recovery uncertain. P&G flags higher commodity costs

Procter & Gamble Company Profile

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.